September 29, 2025
Advance Online

Advance Online
TREMFYA® for Pediatric Patients 6 Years and Older
This is the first IL-23 inhibitor approved for pediatric psoriasis and psoriatic arthritis.
This is the first IL-23 inhibitor approved for pediatric psoriasis and psoriatic arthritis.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.